Laboratory Automation - only the white coats remain
Reducing the time and cost of clinical tests will help us beat the big killers, then guide our personalised rejuvenation programmes
Join the club for FREE to access the whole archive and other member benefits.
It's surprising how much pharmaceutical research to date has been more art than science. Computing power is still a long way off predicting the properties of proteins and cells from their DNA, so until then the more research that can be accelerated by automation (e.g. lab robots, lab-on-chip) the better.
And this is being driven by the big pharma companies who can't afford the failure rate at late stage drug development, or worse after release which can result in multi-billion law suits. I attended an excellenty talk by the chief scientific office for GE Healthcare recently and they are mass producing stem cell lines, and the machinery to test them, so that drugs can be tested for cardio-toxicity much earlier on in the development process.
Tap on icon for description, click on resource name for more details.
Biotechnology company that develops and manufactures human therapeutics for various illness and diseases
Company focused on the discovery and development of therapies for patients with neurodegenerative diseases
Company that develops a technology platform to improve the cancer drug development process
Drug discovery and development company focused on cancer patients
A web-based life sciences lab, developed by scientists for scientists
Biotechnology company that provides robotic solutions for biology labs
Drug development company promoting longevity and finding treatments for age-related diseases
Specialty pharmaceutical company that identifies, develops and commercializes innovative treatments
Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs)
Pharmaceutical services company which is the world leader in testing vaccines and antivirals through human challenge studies
Reducing the time and cost of clinical tests will help us beat the big killers, then guide our personalised rejuvenation programmes
Phys.org - 30-Nov-2021
Simple, low-cost tool for improving screening in remote and low-resource areas
Read more...Nature - 29-Sep-2021
Challenges of mass producing stem cells and how 3 companies are attempting to overcome them
Read more...Medgadget - 14-Jun-2021
Rapid 3D printing of human tissue constructs aids in screening potential drug candidates
Read more...Chalmers University of Technology - 03-Jun-2021
Speeds up drug discovery process, allowing researchers to find new treatments for deadly diseases
Read more...Kumamoto University - 28-Jan-2021
New automated system with AI searches genes, drugs to extend human healthy lifespan
Read more...